SEIKAGAKU CORP.
Company Snapshot
Founded: 1947
Entity Type: Public
Employees: 1,075
Region: Japan
Revenue: $258.7 Millions
Revenue Year: 2024
Headquarter: Tokyo, Japan
Key Geographics: North America, Asia-Pacific
Corporate Address: Marunouchi Center Building 10floor 6-1, Marunouchi 1-chome Chiyoda-ku, Tokyo 100-0005 Japan Tel. +(81)-3-5220-8950 www.seikagaku.co.jp
Company Overview
Seikagaku Corp. is engaged in manufacturing and marketing pharmaceuticals and medical devices (primarily related to glycoconjugates). The company was established in 1947. Its medical device product line includes Gel-One branded, cross-linked hyaluronate hydrogel for knee osteoarthritis. The company also provides bulk products, like hyaluronic acid (primarily used as a raw material for the improvement of joint functioning, ophthalmic surgical aids, and eye drops) and chondroitin sulfate (used as a raw material in ophthalmic products, such as eye drops and eyewashes, and nutritional drinks).
Financial Highlights (FY 2024)
Net Revenue: ***
R&D expenses: ***
Operating Income: ***
This information is available for BCC Research members only.
SEIKAGAKU CORP. In News
Company's Business Segments
- Pharmaceuticals Business : This segment manufactures and sells pharmaceuticals, medical devices, and bulk products based on glycoconjugates, such as hyaluronic acid.
- LAL Business : This segment manufactures and sells endotoxin-detecting reagents used in the quality control of pharmaceuticals and medical devices in Japan and worldwide.
Applications/End User Industries
- Pharmaceuticals
- Medical Devices
- Healthcare
- Life Sciences
BCC Research Beacon 